SJN
Sung Ji Nam Scotiabank Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
24
Avg Return
Past Year
Past Year
40%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
66.7%
Neutral
33.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Devices
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Sector Outperform
Maintained
| $60 |
44%
downside
| 3 | +48% |
0
%
| 31 Jul ‘25 3 months ago |
|
|
|
Sector Outperform
Maintained
| $75 |
16%
upside
| 2 | -4.5% |
0
%
| 11 Jul ‘25 4 months ago |
|
|
|
Sector Outperform
Upgraded
| $275 |
20%
upside
| 2 | +11% |
0
%
| 11 Jul ‘25 4 months ago |
|
|
|
Sector Outperform
Upgraded
| $590 |
1%
downside
| 4 | +38% |
0
%
| 11 Jul ‘25 4 months ago |
|
|
|
Sector Perform
Downgraded
| $125 |
4%
downside
| 1 | – |
–
| 11 Jul ‘25 4 months ago |
|
|
|
Sector Outperform
Maintained
| $40 |
0%
upside
| 1 | +142% |
0
%
| 21 May ‘25 6 months ago |
|
|
|
Sector Outperform
Maintained
| $40 |
408%
upside
| 1 | +45% |
0
%
| 21 May ‘25 6 months ago |
|
|
|
Sector Perform
Downgraded
| $6 |
21%
downside
| 2 | -50% |
0
%
| 21 May ‘25 6 months ago |
|
|
|
Sector Perform
Maintained
| $4 |
121%
upside
| 1 | – |
–
| 2 Apr ‘25 7 months ago |
|
|
|
Sector Outperform
Maintained
| $18 |
144%
upside
| 1 | +2.6% |
0
%
| 25 Mar ‘25 8 months ago |
|
|
|
Sector Outperform
Maintained
| $2 |
16%
downside
| 1 | +80% |
0
%
| 25 Mar ‘25 8 months ago |
|
|
|
Sector Outperform
Maintained
| $73 |
28%
downside
| 1 | +106% |
0
%
| 24 Feb ‘25 9 months ago |
|
|
|
Sector Outperform
Maintained
| $12 |
39%
downside
| 1 | +161% |
0
%
| 13 Feb ‘25 9 months ago |
|
|
|
Sector Outperform
Upgraded
| $450 |
11%
upside
| 2 | +6.6% |
0
%
| 13 Feb ‘25 9 months ago |
|
|
|
Sector Outperform
Maintained
| $62 |
96%
upside
| 1 | -40% |
0
%
| 4 Feb ‘25 9 months ago |
|